Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Orally Disintegrating Drug market was valued at US$ 2013.7 million in 2022 and is projected to reach US$ 3702.7 million by 2029, at a CAGR of 9.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The orally disintegrating drug market is being driven by several factors. One of the primary drivers is the growing demand for convenient and patient-friendly medication delivery methods. Orally disintegrating drugs offer an advantage over traditional oral tablets as they quickly dissolve in the mouth without the need for water, making them easier to administer, particularly for individuals with swallowing difficulties, pediatric patients, and the elderly. Additionally, the increasing prevalence of chronic diseases and the need for efficient and immediate drug absorption have fueled the demand for orally disintegrating drugs. Furthermore, advancements in formulation technologies and taste-masking techniques have improved the palatability of these drugs, enhancing patient compliance. Overall, the demand for orally disintegrating drugs is driven by the need for convenience, improved patient experience, and enhanced drug delivery options in the pharmaceutical market.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Drug. This report contains market size and forecasts of Orally Disintegrating Drug in global, including the following market information:
Global Orally Disintegrating Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Orally Disintegrating Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Orally Disintegrating Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Orally Disintegrating Drug Market Segment Percentages, by Type, 2022 (%)
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Global Orally Disintegrating Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Orally Disintegrating Drug Market Segment Percentages, by Application, 2022 (%)
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Global Orally Disintegrating Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Orally Disintegrating Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orally Disintegrating Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Orally Disintegrating Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson and Johnson
GSK
Otsuka
Vartris
Teva
Pfizer
Eli Lilly and Company
Merck
Eisai
AstraZeneca
Bristol-Myers Squibb
Conquer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Orally Disintegrating Drug, market overview.
Chapter 2: Global Orally Disintegrating Drug market size in revenue.
Chapter 3: Detailed analysis of Orally Disintegrating Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Orally Disintegrating Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Orally Disintegrating Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Orally Disintegrating Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orally Disintegrating Drug Overall Market Size
2.1 Global Orally Disintegrating Drug Market Size: 2022 VS 2029
2.2 Global Orally Disintegrating Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Orally Disintegrating Drug Players in Global Market
3.2 Top Global Orally Disintegrating Drug Companies Ranked by Revenue
3.3 Global Orally Disintegrating Drug Revenue by Companies
3.4 Top 3 and Top 5 Orally Disintegrating Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Orally Disintegrating Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Orally Disintegrating Drug Players in Global Market
3.6.1 List of Global Tier 1 Orally Disintegrating Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Orally Disintegrating Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Orally Disintegrating Drug Market Size Markets, 2022 & 2029
4.1.2 Anti-Psychotics Drug
4.1.3 Anti-Epileptics Drug
4.1.4 Other
4.2 By Type - Global Orally Disintegrating Drug Revenue & Forecasts
4.2.1 By Type - Global Orally Disintegrating Drug Revenue, 2018-2023
4.2.2 By Type - Global Orally Disintegrating Drug Revenue, 2024-2029
4.2.3 By Type - Global Orally Disintegrating Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Orally Disintegrating Drug Market Size, 2022 & 2029
5.1.2 CNS Diseases
5.1.3 Gastrointestinal Diseases
5.1.4 CVS Diseases
5.1.5 Other
5.2 By Application - Global Orally Disintegrating Drug Revenue & Forecasts
5.2.1 By Application - Global Orally Disintegrating Drug Revenue, 2018-2023
5.2.2 By Application - Global Orally Disintegrating Drug Revenue, 2024-2029
5.2.3 By Application - Global Orally Disintegrating Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Orally Disintegrating Drug Market Size, 2022 & 2029
6.2 By Region - Global Orally Disintegrating Drug Revenue & Forecasts
6.2.1 By Region - Global Orally Disintegrating Drug Revenue, 2018-2023
6.2.2 By Region - Global Orally Disintegrating Drug Revenue, 2024-2029
6.2.3 By Region - Global Orally Disintegrating Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Orally Disintegrating Drug Revenue, 2018-2029
6.3.2 US Orally Disintegrating Drug Market Size, 2018-2029
6.3.3 Canada Orally Disintegrating Drug Market Size, 2018-2029
6.3.4 Mexico Orally Disintegrating Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Orally Disintegrating Drug Revenue, 2018-2029
6.4.2 Germany Orally Disintegrating Drug Market Size, 2018-2029
6.4.3 France Orally Disintegrating Drug Market Size, 2018-2029
6.4.4 U.K. Orally Disintegrating Drug Market Size, 2018-2029
6.4.5 Italy Orally Disintegrating Drug Market Size, 2018-2029
6.4.6 Russia Orally Disintegrating Drug Market Size, 2018-2029
6.4.7 Nordic Countries Orally Disintegrating Drug Market Size, 2018-2029
6.4.8 Benelux Orally Disintegrating Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Orally Disintegrating Drug Revenue, 2018-2029
6.5.2 China Orally Disintegrating Drug Market Size, 2018-2029
6.5.3 Japan Orally Disintegrating Drug Market Size, 2018-2029
6.5.4 South Korea Orally Disintegrating Drug Market Size, 2018-2029
6.5.5 Southeast Asia Orally Disintegrating Drug Market Size, 2018-2029
6.5.6 India Orally Disintegrating Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Orally Disintegrating Drug Revenue, 2018-2029
6.6.2 Brazil Orally Disintegrating Drug Market Size, 2018-2029
6.6.3 Argentina Orally Disintegrating Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Orally Disintegrating Drug Revenue, 2018-2029
6.7.2 Turkey Orally Disintegrating Drug Market Size, 2018-2029
6.7.3 Israel Orally Disintegrating Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Orally Disintegrating Drug Market Size, 2018-2029
6.7.5 UAE Orally Disintegrating Drug Market Size, 2018-2029
7 Orally Disintegrating Drug Companies Profiles
7.1 Johnson and Johnson
7.1.1 Johnson and Johnson Company Summary
7.1.2 Johnson and Johnson Business Overview
7.1.3 Johnson and Johnson Orally Disintegrating Drug Major Product Offerings
7.1.4 Johnson and Johnson Orally Disintegrating Drug Revenue in Global Market (2018-2023)
7.1.5 Johnson and Johnson Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Orally Disintegrating Drug Major Product Offerings
7.2.4 GSK Orally Disintegrating Drug Revenue in Global Market (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Otsuka
7.3.1 Otsuka Company Summary
7.3.2 Otsuka Business Overview
7.3.3 Otsuka Orally Disintegrating Drug Major Product Offerings
7.3.4 Otsuka Orally Disintegrating Drug Revenue in Global Market (2018-2023)
7.3.5 Otsuka Key News & Latest Developments
7.4 Vartris
7.4.1 Vartris Company Summary
7.4.2 Vartris Business Overview
7.4.3 Vartris Orally Disintegrating Drug Major Product Offerings
7.4.4 Vartris Orally Disintegrating Drug Revenue in Global Market (2018-2023)
7.4.5 Vartris Key News & Latest Developments
7.5 Teva
7.5.1 Teva Company Summary
7.5.2 Teva Business Overview
7.5.3 Teva Orally Disintegrating Drug Major Product Offerings
7.5.4 Teva Orally Disintegrating Drug Revenue in Global Market (2018-2023)
7.5.5 Teva Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Orally Disintegrating Drug Major Product Offerings
7.6.4 Pfizer Orally Disintegrating Drug Revenue in Global Market (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Company Summary
7.7.2 Eli Lilly and Company Business Overview
7.7.3 Eli Lilly and Company Orally Disintegrating Drug Major Product Offerings
7.7.4 Eli Lilly and Company Orally Disintegrating Drug Revenue in Global Market (2018-2023)
7.7.5 Eli Lilly and Company Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Orally Disintegrating Drug Major Product Offerings
7.8.4 Merck Orally Disintegrating Drug Revenue in Global Market (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 Eisai
7.9.1 Eisai Company Summary
7.9.2 Eisai Business Overview
7.9.3 Eisai Orally Disintegrating Drug Major Product Offerings
7.9.4 Eisai Orally Disintegrating Drug Revenue in Global Market (2018-2023)
7.9.5 Eisai Key News & Latest Developments
7.10 AstraZeneca
7.10.1 AstraZeneca Company Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Orally Disintegrating Drug Major Product Offerings
7.10.4 AstraZeneca Orally Disintegrating Drug Revenue in Global Market (2018-2023)
7.10.5 AstraZeneca Key News & Latest Developments
7.11 Bristol-Myers Squibb
7.11.1 Bristol-Myers Squibb Company Summary
7.11.2 Bristol-Myers Squibb Business Overview
7.11.3 Bristol-Myers Squibb Orally Disintegrating Drug Major Product Offerings
7.11.4 Bristol-Myers Squibb Orally Disintegrating Drug Revenue in Global Market (2018-2023)
7.11.5 Bristol-Myers Squibb Key News & Latest Developments
7.12 Conquer
7.12.1 Conquer Company Summary
7.12.2 Conquer Business Overview
7.12.3 Conquer Orally Disintegrating Drug Major Product Offerings
7.12.4 Conquer Orally Disintegrating Drug Revenue in Global Market (2018-2023)
7.12.5 Conquer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
